cicletanine has been researched along with cyclic gmp in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (66.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YF; Durand, J; Esunge, P; Jin, HK; Oparil, S; Yang, RH | 1 |
| Bentley, RG; Cumiskey, WR; Hamel, LT; O'Connor, B; Pagani, ED; Silver, PJ; Van Aller, G | 1 |
| Barthelemy, C; Berlin, I; Deray, G; Jacobs, C; Legrand, JC; Maistre, G; Masson, F | 1 |
| Bor, P; Braquet, PG; Esanu, A; Jakab, I; Koltai, M; Lonovics, J; Szilvassy, Z; Tarrade, T | 1 |
| Deitmer, P; Golenhofen, K; Noack, T | 1 |
| Angielski, S; Jankowski, M; Kalinowski, L; Szczepanska-Konkel, M | 1 |
| Izumi, M; Karaki, H; Mitsui-Saito, M; Ozaki, H | 1 |
| López-Novoa, JM; Morales, AI; Pérez-Barriocanal, F; Valdivielso, JM | 1 |
| Bagrov, AY; Dmitrieva, RI; Dorofeeva, NA; Droy-Lefaix, MT; Fedorova, OV; Lakatta, EG; Lopatin, DA | 1 |
| Akamatsu, N; Higaki, T; Hiranuma, O; Imamura, H; Kawahara, T; Komatsu, S; Kono, Y; Nakagawa, M; Sato, T; Sawada, S; Tada, Y; Tamagaki, T; Tsuda, Y; Tsuji, H; Yamasaki, S | 1 |
| Németh, J; Pankucsi, C; Peitl, B; Szilvássy, Z | 1 |
| Drimba, L; Hegedüs, C; Németh, J; Peitl, B; Sári, R; Szilvássy, Z; Yin, D | 1 |
1 trial(s) available for cicletanine and cyclic gmp
| Article | Year |
|---|---|
Cicletanine does not affect plasma atrial natriuretic peptide concentration in healthy subjects.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Diuretics; Double-Blind Method; Exercise; Heart Rate; Humans; Male; Pyridines; Sodium; Urine | 1990 |
11 other study(ies) available for cicletanine and cyclic gmp
| Article | Year |
|---|---|
Antihypertensive effect of cicletanine is exaggerated in NaCl-sensitive hypertension.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Diuretics; Epinephrine; Heart Rate; Hypertension; Male; Pyridines; Rats; Rats, Inbred SHR; Sodium Chloride; Sodium, Dietary | 1991 |
Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Antihypertensive Agents; Calcium; Calmodulin; Cyclic GMP; Diuretics; Female; Guinea Pigs; Male; Myosin-Light-Chain Kinase; Nitroprusside; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Inbred Strains; Vasodilation | 1991 |
Cicletanine attenuates overdrive pacing-induced global myocardial ischemia in rabbits: possible role of cardiac cyclic nucleotides.
Topics: Animals; Antihypertensive Agents; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic GMP; Electrocardiography; Hemodynamics; Male; Myocardial Ischemia; Myocardium; Pyridines; Rabbits | 1993 |
Inhibitory effects of cicletanine on smooth muscle in comparison to those of nifedipine and sodium nitroprusside.
Topics: Animals; Anti-Arrhythmia Agents; Cyclic GMP; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Nifedipine; Nitroprusside; Norepinephrine; Papaverine; Pyridines; Rabbits; Rats | 1993 |
Modulation by low sodium intake of glomerular response to cicletanine and atrial natriuretic factor.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Cyclic GMP; Diuretics; Glomerular Filtration Rate; Male; Pyridines; Rats; Rats, Wistar; Sodium, Dietary | 1997 |
Cicletanine-induced decreases in cytosolic Ca2+ level and contraction in vascular smooth muscle.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Caffeine; Calcium; Central Nervous System Stimulants; Cyclic GMP; Cytosol; Dinoprost; Dose-Response Relationship, Drug; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium Chloride; Pyridines; Rabbits; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Vasodilation | 1998 |
Effect of cicletanine on renal cGMP production.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cyclic GMP; Diuretics; Female; Glomerular Filtration Rate; Kidney; Pyridines; Rats; Rats, Wistar; Sodium Chloride | 1998 |
Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
Topics: Animals; Antihypertensive Agents; Brain; Bufanolides; Cyclic GMP; Endothelin-1; Enzyme Inhibitors; Humans; In Vitro Techniques; Male; Mesenteric Arteries; Middle Aged; Protein Kinase C; Pyridines; Rats; Sodium-Potassium-Exchanging ATPase; Vasoconstriction | 2000 |
Effect of cicletanine on the nitric oxide pathway in human umbilical vein endothelial cells.
Topics: Antihypertensive Agents; Calcium; Cells, Cultured; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Humans; Inositol 1,4,5-Trisphosphate; Intracellular Fluid; Nitric Oxide; Pyridines; Umbilical Veins | 2001 |
Insulin sensitization induced by oral cicletanine in conscious rabbits.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Pressure; Blood Vessels; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Glucose Clamp Technique; Heart Rate; Hypercholesterolemia; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Myocardium; Nitric Oxide; Pyridines; Rabbits; Rosiglitazone; Thiazolidinediones | 2006 |
Beneficial cardiac effects of cicletanine in conscious rabbits with metabolic syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiac Pacing, Artificial; Cholesterol, Dietary; Consciousness; Cyclic AMP; Cyclic GMP; Diet, High-Fat; Disease Models, Animal; Electrocardiography; Heart Rate; Lipids; Male; Metabolic Syndrome; Myocardium; Nitric Oxide; Pyridines; Rabbits; Sotalol; Time Factors | 2012 |